Taltz in Combination With Enstilar for Psoriasis
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Recruiting
Sponsor: Psoriasis Treatment Center of Central New Jersey
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?This trial is testing if adding Enstilar Foam to patients already using Taltz can help treat plaque psoriasis. The study focuses on patients who have been on Taltz for a significant period and have moderate psoriasis affecting 3%-8% of their body. Enstilar reduces skin symptoms, while Taltz calms the immune system.
Eligibility Criteria
Inclusion Criteria
Male or female adult ≥ 18 years of age;
Diagnosis of chronic plaque-type
Body Surface Area between 3%-8%.
+4 more
Participant Groups
1Treatment groups
Experimental Treatment
Group I: EnstilarExperimental Treatment1 Intervention
Enstilar foam
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Psoriasis Treatment Center of Central New JerseyEast Windsor, NJ
Loading ...
Who Is Running the Clinical Trial?
Psoriasis Treatment Center of Central New JerseyLead Sponsor
Eli Lilly and CompanyIndustry Sponsor